Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 17/20 | 0.69 |
| ▸ | KCNH2 | Q12809 | 7/20 | 0.69 |
| ▸ | CDK1 | P06493 | 9/20 | 0.66 |
| ▸ | CDK4 | P11802 | 1/20 | 0.66 |
| ▸ | CDKL1 | Q00532 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1447545 | 0.89 | CDK2 (0.82) | CDK2KCNH2CDK1CDK4 | |
| SCHEMBL1447350 | 0.89 | CDK2 (0.82) | CDK2KCNH2CDK1CDK4 | |
| SCHEMBL1447616 | 0.88 | CDK2 (0.83) | CDK2KCNH2CDK1CDK4 | |
| SCHEMBL1447236 | 0.88 | CDK2 (0.83) | CDK2KCNH2CDK1CDK4 | |
| SCHEMBL1447182 | 0.88 | CDK2 (0.83) | CDK2KCNH2CDK1CDK4 | |
| SCHEMBL4247391 | 0.86 | CDK2 (0.69) | CDK2KCNH2CDK1CDK4 | |
| SCHEMBL1447609 | 0.85 | CDK2 (0.75) | CDK2KCNH2CDK1CDK4CDKL1 | |
| SCHEMBL1447688 | 0.84 | KCNH2 (0.73) | CDK2KCNH2CDK1CDK4CDKL1 | |
| SCHEMBL1448237 | 0.84 | CDK2 (0.84) | CDK2KCNH2CDK1CDK4 | |
| SCHEMBL3539230 | 0.83 | CDK2 (0.54) | CDK2KCNH2CDK1CDK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2301928-A1 | Imidazolyl-pyrimidine compounds for use in the treatment of proliferative disorders | AstraZeneca AB (SE) | 2011-03-30 | — | — | EP | disclosed |